For information about PROMETA and it's use in treating alcohol, cocaine and methamphetamine, click here. For information about SUBOXONE and it's use in treating opiate dependency, click here. For info on VIVITROL and it's use in treating alcohol dependency, click here. PROMETA targets the biology of addiction Medical research has shown that addiction is a disease associated with biochemical changes in the brain. These changes in brain chemistry play a significant role in the physical symptoms of substance dependence, including cravings and withdrawal. What Is PROMETA? PROMETAŽ is an integrated, physician-based treatment that is designed to target the adverse changes in brain chemistry that occur with alcohol, cocaine, or methamphetamine dependence. PROMETA treatment is generally performed in an outpatient setting and typically requires just 2–3 visits* for the initial treatment, followed by one month of prescription medications and ongoing professional counseling. The PROMETA Treatment The PROMETA treatment protocol includes: The initial treatment involves prescription medication and nutritional supplements administered in a physician-supervised setting. The patient then receives one month of prescription medications and nutritional supplements. Professional counseling following the initial treatment typically includes individual and/or group therapy. There are two PROMETA treatment protocols: PROMETA for alcohol dependence PROMETA for stimulant dependence (cocaine or methamphetamines). *Treatment for cocaine or methamphetamine dependence includes a second physician-supervised treatment of 2 visits on consecutive days, about 3 weeks after the initial treatment. Breaking the Cycle of Dependence Repeated drug use causes brain adaptations that produce cravings, leading to more drug use. PROMETA is an integrated, physician-based treatment that is designed to help reduce your cravings and reverse some brain adaptations, helping maintain your abstinence. PROMETA Is Not for Everyone Treatment with PROMETA is not appropriate for everyone. The PROMETA-treating physician must make the treatment decision for each individual patient regarding the appropriateness of using the PROMETA treatment protocols during detoxification or any other stage of recovery. PROMETA is not designed for use with those diagnosed with dependence to opiates, benzodiazepines, or addictive substances other than alcohol or stimulants. PROMETA may not be appropriate for use in all patients, and should not be used in women who are or who plan to be pregnant or nursing during the course of treatment. PROMETA is not designed for use in patients under the age of 18. Other prescribing restrictions may apply. HythiamŽ does not provide medical advice or medical treatment, and makes no claims about the effectiveness and suitability of PROMETA in general or for any individual patient.